INVEST IN VXTRA HEALTH TODAY!
Leveraging over a decade of relevant expertise resulting from the management of self-insured health plans for large, independent medical practices in 14 states, Vxtra Health is not a start-up. Combining our relevant expertise and $1,650,000 in seed capital from our founders, innovative doctors and strategic industry partners, Vxtra Health is a start over.
An underserved category, the self-insured, middle market employer space is poised for disruption. Unsustainable healthcare costs on top of postpandemic HR challenges are stimulating innovative employers to “think differently.” Combined, these dynamics have created the opportunity for a transformational vision to disrupt the commercial health insurance and PBM marketplace.
The self-insured, middle market employer space (200 – 2,000 employees) is a large, but scalable, niche category. It is a highly fragmented, $26 billion market growing at 11% annually that is ripe for disruption. (Source) Vxtra Health’s end-to-end, open source solution addresses the unmet needs of self-insured, middle market employers. Our solutions focus on leveraging local assets and go beyond emulating the solutions being marketed to Fortune 500 companies.
THE PROBLEM
Surveys show that people will abandon recommended treatments altogether
because insurance companies will deny coverage unless a cheaper alternative
is available. In other circumstances, red tape and bureaucratic challenges
contribute significantly – to the detriment of the patient’s health – delays in care.
Pre-authorization processes impede the timely and efficient provision of care.
It questions doctors’ decisions and never compensates them, or their staff, for
the extra time and efforts spent navigating the “red tape.” Nor does it assume
the downstream medical and/or legal responsibility for patient outcomes.
Further, traditional health insurance companies and PBMs are handicapped
by legacy technologies and arcane processes that are inefficient and do not
deliver the contemporary user experience the marketplace expects today. Net
promoter scores for health insurance companies and PBMs are among the
lowest in the US.
THE SOLUTION
For too long, health insurance companies and PBMs have dictated processes,
procedures, and prescriptions that add to the expense of providing healthcare,
and often in direct conflict with the experienced-based decisions of doctors.
Vxtra Health’s vision and go-to-market strategy is transformational. Our
competitive advantage is based on our capacity to align the interests of local,
self-insured, middle market employers and the best local doctors. We
collaborate and partner with motivated doctors who want to promote the
economic, clinical, and experiential value of guideline-based medicine without
the friction and cost of low-value middlemen.
Healthcare is local. Our contrarian approach attracts the best doctors as well
as the most innovative self-insured, middle market employers.
No Unnecessary Pre-Authorizations
Vxtra Health leverages technology-enabled transparency and better data management strategies and tactics to create newfound value. We are hyperfocused on reducing friction and eliminating the unnecessary costs associated with low value middlemen wherever possible.
As a result, data-driven collaboration with doctors can eliminate avoidable costs, and enable employers to reduce copays and deductibles for their employees. Eliminating unnecessary pre-authorizations will reduce hassles, time away from work, and improve the doctor-patient experience. Moreover, it will reduce overhead costs for doctors.
Open Source Technology
Vxtra Health differentiates its service offering by delivering a better user experience. We leverage a more cost-efficient, user-friendly technology platform. Our best-in-class “mobile-first” component strategy optimizes enterprise-wide communications by utilizing fully integrated, cloud-based, open source technologies that allows us to leverage AI and machine learning. This approach radically improves medical and pharmacy claims administration, client relationship management, member communications and navigation, and most importantly – doctor-centric collaboration. All of this results in highly personalized member navigation and care management.
THE MARKET
Vxtra Health competes directly with legacy health insurance companies - Aetna, Anthem, regional Blue Cross Blue Shield plans, Cigna, HUMANA, United Health Care, etc., legacy PBM’s, and a limited number of third party administrators that utilize equally arcane technologies, deploy the same cumbersome processes, and offer the same restrictive PPO networks and PBMs.
Potential competitors are currently focused on serving Fortune 500 companies, and may elect to enter the middle-market space. Referred to as “member navigation,” it is a category that affirms the opportunity to disrupt the control that health insurance companies have enjoyed over the past two decades. In addition to the fees Fortune 500 companies are paying to health insurance companies, these well capitalized “member navigation” companies derive revenues by providing curated support within the network offerings of health insurance companies and pharmacy benefits managers. Further evidence that low satisfaction scores and an inability to control cost and quality is creating opportunities to compete against legacy health insurance companies and PBMs.
This burgeoning, and complimentary, category attracted $15B in digital health
Vxtra Health focuses on building, marketing, and managing health benefits solutions that are tailored to meet the discreet, and most often unique, healthcare needs of local self-insured, middle market employers. A majority of their employees tend to be concentrated in markets where their home office is located. Vxtra Health creates newfound value by focusing on creating economic and operational efficiencies by leveraging and aligning local interests and assets.
OUR TRACTION
Strategic Milestones
OUR LEADERSHIP
Vxtra Health’s leadership team has over thirty years’ experience creating value by collaborating with doctors, not frustrating them. Our expertise in executing this critical function is unique in the industry. We are able to recruit, partner, and establish a nationwide network of local, influential doctors that are established healthcare and community leaders.
Vxtra Health delivers solutions that address the unmet needs of a large, addressable niche in the commercial health insurance marketplace. We create newfound value by collaborating with doctors to develop, market, and manage value-based health plans without the hassles for self-insured, middle market employers (200 - 2,000 employees). Universally, employers, employees and doctors want health plans without the hassles that deliver better health outcomes at a more affordable price.
Larry Hightower
Chief Executive Officer
For over 30 years, Larry has combined his relationship management skills with business acumen to bring to market micro-surgical procedures, implantable devices, diagnostic imaging instrumentation, clinical information services and e-clinical trials applications. He has held key marketing and leadership roles developing go-to-market strategies in cardiology, urology, ophthalmology, gastroenterology, emergency medicine and radiology.
Those relationships and experiences continue to prove valuable in attracting doctors to lead the development of a next generation strategy for lowering costs and improving health outcomes.
Charlie Elliott
President
Elliott held consulting roles with Accenture, Navigant Consulting, Optum Advisory Services and KPMG; developed the operational performance improvement division for Summa Health; and served as business manager for the Cleveland Health Network Integrated Services Organization (Cleveland Clinic Health System). He is a member of the American College of Healthcare Executives, the Georgia Association of Healthcare Executives and the Healthcare Financial Management Association. Elliott holds a Certificate in Executive Health System Management from Case Western Reserve University in Cleveland, Ohio, and a Master of Business Administration from the University of Akron.
Elliott is keenly aware of the value of physician-led collaboration to improve outcomes, having invested a large portion of his career in major teaching hospitals. Thus, he respects Vxtra Health’s vision of returning the physician back to the center of the care delivery process.
Tino Valentino
Chief Financial Officer
Tino received his Bachelor of Science degree in accounting from Ohio Dominican University and is a certified public accountant.
Robert DiLoreto, MD
Director and CMIO
Dr. Di Loreto has been a consultant and urology advisory panel member for the Food and Drug Administration’s Center for Devices and Radiological Health for more than 30 years. He was the co-founder and president of the Michigan Institute of Urology, the nation’s first large urology super group, as well as the medical director of Michigan Mobile Lithotripsy, the co-founder and board member of Michigan Cryogenic Equipment Services and Michigan Mobile Urology Services, the co-founder and medical director of Great Lakes Lithotripsy, and chief medical information officer for Integra Connect. The former chief of urology and past president of medical staff at Saint John Hospital and Medical Center in Detroit, Dr. Di Loreto is also a former board member and chairman of the hospital and health system.
In his own words, Dr. Di Loreto explains “No system previously existed to meld disparate data sources across many sources; independent physician practices, Health Systems, Insurance companies, Third party administrators (Electronic Medical Records, Lab data, Billing data, TPA data, etc.) that can now be aggregated and used to provide nearly real-time physician partners to practice ‘Right Medicine, at the Right Time, for the Right Reasons’ for the best patient’s care with the aid of Clinical Concierge Navigators. Our ability to minimize partner physician’s practice problems (ex. Prior Authorization) as well as maximize partner patient’s care and minimize partner employers never-ending insurance costs increases puts Vxtra Health in a unique position moving forward.”
Brian Coffey
Chief Information Officer
Brian has also utilized his extensive expertise to serve as a trusted advisor to numerous start-ups in the areas of predictive analytics software, data management and IoT software, text analytics, machine learning-driven digital marketing and CRM, and an artificial intelligence-driven, model-based automated testing platform.
Jerry Quinn
Chief Operating Officer
Most recently, Jerry served as National Benefits Practice Leader at CLVL Solutions where he was responsible for the delivery of employee health benefits consulting services to multinational medical devices, pharmaceutical and consumer packaged goods manufacturing companies. He cultivated strategic alliances with a variety of best-in-class national and regional employee health insurers and specialized health plan vendors in delivering products and services to corporate clients. He possesses a deep knowledge of health plan financing, administration, provider networks, care management services, pharmaceutical benefit management services and wellness programs.
Prior to his employee health benefits consulting role, Jerry served as Senior Vice President and East Regional Director at First Health. Jerry was one of 14 senior management investors who launched venture-backed Alta Health Strategies which ultimately became First Health, a publicly traded Managed Health Care Company. The keys to growth included adding Care Management, building National provider networks, adding Prescription Benefits Management services, and Stop Loss coverage to augment excellent health claims administration services.
Jerry has participated in several Charitable Fund-Raising initiatives for organizations such as The American Cancer Society, Johns Hopkins Children’s Center Pediatric Trauma Service and Special Olympics. He is a former School Board member of The Shrine of the Sacred Heart in Baltimore, MD.
A native of Brookline, MA, Jerry is a graduate of Middlebury College in Middlebury, VT.
Mel Mendenhall
Chief Sales Officer
Mel has assisted more than 100 companies in transitioning their health plan from a fully insured arrangement to a self-funded plan.
Gail Tolbert
Chief People Officer
As the founder and CEO of OutsideTheBox, LLC, Gail helps women optimize their full potential and works with executive leadership teams to achieve business and personal goals. Additionally, she is a John Mattone Intelligent Leadership Certified Coach and a certified practitioner of Predictive Index behavioral and cognitive assessments, with a Master of Science in human resources management. She was awarded the SHRM Pegasus Award for HR Leadership and Innovation and the Key Scholarship Award for Academic Excellence and HR Leadership from the Bebee Institute of Personnel and Employee Relations.
Tim Attebery
Chairman, Board of Directors
Tim previously served as the CEO of the American College of Cardiology (ACC), CEO of MedAxiom, and president and CEO of the Holston Valley Medical Center. Prior to his CEO position at the health system, he was the CEO of the largest most influential cardiology practices in Evansville, IN, Columbia, SC, and Kingsport, TN. Additionally, Tim served on the boards of the Cardiology Advocacy Alliance and the Cardiology Leadership Alliance and was instrumental in founding the Society of Cardiovascular Computed Technology and MedAxiom. He holds a bachelor's degree in business administration from Western Governors University in Salt Lake City, a Master of Business Administration from the University of Tennessee-Knoxville Haslam College of Business and a doctorate in healthcare leadership from the University of Alabama at Birmingham
Robert Merold
Director
Bob spent the first decade of his career advancing to category manager at Procter & Gamble before becoming director of marketing for Bristol-Myers Squibb. He then served as global senior vice president of product for IMS Health and ran a cutting-edge genomic startup, followed by one of the first commercial efforts in the healthcare NLP data mining space. Bob has served on corporate boards, as chief of strategic initiatives for the health information technology platform CancerLinQ™. He is currently the managing director of Execullence LLC, a boutique consultancy that serves in an advisory capacity to high performance management teams in healthcare and venture and/or M&A finance.
Maximum Number of Shares Offered subject to adjustment for bonus shares
Company | : | Vxtra Health Plan, Inc. |
Corporate Address | : | 2700 Cumberland Parkway, Suite 140, Atlanta, GA 30339 |
Offering Minimum | : | $10,000.00 |
Offering Maximum | : | $5,000,000.00 |
Minimum Investment Amount(per investor) | : | $400.00 |
Offering Type | : | Equity |
Security Name | : | Non-Voting Common Stock |
Minimum Number of Shares Offered | : | 25,000 |
Maximum Number of Shares Offered | : | 12,500,000 |
Price per Share | : | $0.40 |
Pre-Money Valuation | : | $15,135,767.00 |
*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
Time-Based
Friends and Family Early Birds
Invest within the first 72 hours and receive an additional 15% bonus shares.
Super Early Bird Bonus
Invest within the next 72 hours and receive an additional 7% bonus shares.
Early Bird Bonus
Invest within the next 7 days and receive an additional 5% bonus shares.
Amount-Based:
$5,000+
Invest $5,000+ and receive 5% Bonus Shares on your investment.
$10,000+
Invest $10,000+ and receive 10% Bonus Shares on your investment.
*All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Vxtra Health Plan, Inc., will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Non-Voting Common Stock at $0.40 / share, you will receive 110 shares of Non-Voting Common Stock, meaning you'll own 110 shares for $40. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are cancelled or fail.
Investors will only receive a single bonus, which will be the highest bonus rate they are eligible for.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments. Salary payments made to one’s self, a friend or relative. Any expense labeled “Travel and Entertainment”. Inter company debt or back payments.
07.13.22
[The following is an automated notice from the StartEngine team].
Hello! Recently, a change was made to the Vxtra Health offering. Here's an excerpt describing the specifics of the change:
Issuer is extending campaign end date.
When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.
04.27.22
[The following is an automated notice from the StartEngine team].
Hello! Recently, a change was made to the Vxtra Health offering. Here's an excerpt describing the specifics of the change:
Issuer has provided updated financials and is extending their campaign 74 days.
When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.
03.28.22
[The following is an automated notice from the StartEngine team].
Hello! Recently, a change was made to the Vxtra Health offering. Here's an excerpt describing the specifics of the change:
The issuer is extending their campaign till 4/30.
When live offerings undergo changes like these on StartEngine, the SEC requires that certain investments be reconfirmed. If your investment requires reconfirmation, you will be contacted by StartEngine via email with further instructions.
02.28.22
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, Vxtra Health has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Vxtra Health be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
01.21.22
We invite you to join us for a progress update followed by a Q&A “town hall” with our CEO, Larry Hightower. Larry and other members of our Advisory Board will provide an overview of our 2021 accomplishments that we believe will position us for a highly targeted 2022 capital raise. An overview of our 2022 business development objectives with respect to our legacy clients as well as our new business opportunities in Charlotte, NC and Atlanta, GA will also be discussed.
REGISTER NOW
https://us02web.zoom.us/webinar/register/WN_T3lmQvh_TWCh79xW7n-jmA
01.18.22
Pops—a transformational virtual diabetes management company is proud to join the movement to restore the value of a hassle-free doctor-patient relationship as a new partner with Vxtra Health. The Pops self-care platform is a perfect complement to Vxtra Health’s focus on providing health plans without the hassles.
“Vxtra Health’s mission is long over due. By collaborating with doctors to create value by improving the doctor-patient experience, POPS will be able to deliver better outcomes for both the person with diabetes and save their employer money at the same time. An honorable endeavor, for sure,” said Pop’s CEO Lonny Stormo
Pops is making the healthy choice the easy choice with Mina, an AI digital coaching platform offering personalized support and encouragement to meet goals while removing barriers to living a healthy lifestyle. Mina is surrounded by simple consumer-experience sensors, starting with a glucose meter that is the simplest way to measure blood glucose on the market. With Pops, it’s time to Own Your Life™. Learn more at https://popsdiabetes.com/
12.20.21
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, Vxtra Health has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Vxtra Health be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
12.03.21
Health insurance companies have hijacked healthcare making it difficult for doctors and nurses to do what they do best. And no one is happy. Change is happening and you can be a part of the movement.
Join this open discussion where we will talk about the impact of pre-authorizations on patient outcomes and the future of healthcare.
COME TO THIS IF YOU ARE
KEY TAKEAWAYS
[1] Top reasons why current trajectory of health insurance is unsustainable
[2] How better data and doctor-patient direct contracting model be applied to the middle market?
https://www.linkedin.com/events/howbighealthinsuranceco-spracti6867087682049208320/
[3] What companies are changing how healthcare is navigated?
11.10.21
[The following is an automated notice from the StartEngine team].
Hello!
As you might know, Vxtra Health has exceeded its minimum funding goal. When a company reaches its minimum on StartEngine, it's about to begin withdrawing funds. If you invested in Vxtra Health be on the lookout for an email that describes more about the disbursement process.
This campaign will continue to accept investments until its indicated closing date.
Thanks for funding the future.
-StartEngine
10.28.21
October 26, 2021
Atlanta, GA, Oct 26, 2021 -- Vxtra Health has announced that Paul Pender, M.D., as Director of Digital Health Communications and Community Relationship Management. After earning his undergraduate degree from Harvard University, his medical degree from the University of Michigan Medical School, and enjoying a successful career as a pioneer in eye surgery, Dr. Pender authored Rebuilding Trust in Healthcare: A Doctor’s Prescription for a Post-Pandemic America.
”I was attracted to Vxtra Health because of the company’s core values. Restoring trust by adopting customer-centered processes and deploying enabling technologies to reduce friction and lower costs for all stakeholders while at the same time maintaining a focus on improving the doctor-patient experience is unique in today’s marketplace. My concern is that trust between the doctor and the patient is continuing to erode based on both internal and external forces. By putting the doctor-patient relationship front and center, I am inspired by Vxtra Health’s capacity to facilitate and leverage physician collaboration with self-insured employers to do what’s right for their employees. Health plans without the hassles for all stakeholders are sorely needed. And it’s doable, ” said Dr. Pender.
“Dr. Pender exemplifies the passion for doing what’s right for patients, a passion that doctors so desperately want to bring back into their universe. His communication skills and capacity to relate to both doctors and patients will greatly enhance our efforts in changing expectations in the marketplace,” said Larry Hightower, CEO of Vxtra Health.
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.
$5,000+
Invest $5,000+ and receive 5% Bonus Shares on your investment.
$10,000+
Invest $10,000+ and receive 10% Bonus Shares on your investment.
0/2500
Cancel anytime before 48 hours before a rolling close or the offering end date.
We want you to succeed and get the most out of your money by offering rewards and memberships!
Your info is your info. We take pride in keeping it that way!
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Important Message
IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE ISSUER AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. INVESTMENTS ON STARTENGINE ARE SPECULATIVE, ILLIQUID, AND INVOLVE A HIGH DEGREE OF RISK, INCLUDING THE POSSIBLE LOSS OF YOUR ENTIRE INVESTMENT.
www.StartEngine.com is a website owned and operated by StartEngine Crowdfunding, Inc. (“StartEngine”), which is neither a registered broker-dealer, investment advisor nor funding portal.
Unless indicated otherwise with respect to a particular issuer, all securities-related activity is conducted by regulated affiliates of StartEngine: StartEngine Capital, LLC, a funding portal registered here with the US Securities and Exchange Commission (SEC) and here as a member of the Financial Industry Regulatory Authority (FINRA), or StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC . You can review the background of our broker-dealer and our investment professionals on FINRA’s BrokerCheck here. StartEngine Secondary is an alternative trading system regulated by the SEC and operated by StartEngine Primary, LLC, a broker dealer registered with the SEC and FINRA. StartEngine Primary, LLC is a member of SIPC and explanatory brochures are available upon request by contacting SIPC at (202) 371-8300.
Investment opportunities posted and accessible through the site are of three types:
1) Regulation A offerings (JOBS Act Title IV; known as Regulation A+), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Primary, LLC (unless otherwise indicated). 2) Regulation D offerings (Rule 506(c)), which are offered only to accredited investors. These offerings are made through StartEngine Primary, LLC. 3) Regulation Crowdfunding offerings (JOBS Act Title III), which are offered to non-accredited and accredited investors alike. These offerings are made through StartEngine Capital, LLC. Some of these offerings are open to the general public, however there are important differences and risks.
Any securities offered on this website have not been recommended or approved by any federal or state securities commission or regulatory authority. StartEngine and its affiliates do not provide any investment advice or recommendation and do not provide any legal or tax advice with respect to any securities. All securities listed on this site are being offered by, and all information included on this site is the responsibility of, the applicable issuer of such securities. StartEngine does not verify the adequacy, accuracy or completeness of any information. Neither StartEngine nor any of its officers, directors, agents and employees makes any warranty, express or implied, of any kind whatsoever related to the adequacy, accuracy, or completeness of any information on this site or the use of information on this site. See additional general disclosures here.
By accessing this site and any pages on this site, you agree to be bound by our Terms of use and Privacy Policy, as may be amended from time to time without notice or liability.
Canadian Investors Investment opportunities posted and accessible through the site will not be offered to Canadian resident investors. Potential investors are strongly advised to consult their legal, tax and financial advisors before investing. The securities offered on this site are not offered in jurisdictions where public solicitation for offerings is not permitted; it is solely your responsibility to comply with the laws and regulations of your country of residence.
California Investors Only – Do Not Sell My Personal Information (800-317-2200). StartEngine does not sell personal information. For all customer inquiries, please write to contact@startengine.com.
StartEngine’s Reg A+ offering is made available through StartEngine Crowdfunding, Inc. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. For more information about this offering, please view StartEngine’s offering circular and risk associated with this offering.